Gene_set	Pathway	Overlap	P-value	Adjusted P-value	Odds Ratio	Combined Score	Genes
KEGG_2021_Human	Ras signaling pathway	4/232	0.00012150057084905025	0.006804031967546815	22.923976608187136	-63.412309433922275	FGF23;KIT;NF1;PTPN11
KEGG_2021_Human	MAPK signaling pathway	4/294	0.0003034351122757725	0.008496183143721631	17.880459770114943	-49.762697732575255	FGF23;KIT;MAP2K7;NF1
KEGG_2021_Human	Neurotrophin signaling pathway	2/119	0.008964014539605185	0.12549620355447258	16.98931623931624	-22.939511285821055	MAP2K7;PTPN11
KEGG_2021_Human	PI3K-Akt signaling pathway	3/354	0.007955391465782094	0.12549620355447258	9.422466422466423	-19.140881053489387	FGF23;GH1;KIT
KEGG_2021_Human	Breast cancer	2/147	0.013449368234662449	0.12716285934786375	13.660344827586206	-18.543070369415922	FGF23;KIT
KEGG_2021_Human	Phospholipase D signaling pathway	2/148	0.0136245920729854	0.12716285934786375	13.565068493150685	-18.413416454449223	KIT;PTPN11
KEGG_2021_Human	JAK-STAT signaling pathway	2/162	0.016183180370760934	0.12946544296608747	12.35625	-16.748364182562245	GH1;PTPN11
KEGG_2021_Human	Rap1 signaling pathway	2/210	0.026381440852868025	0.1846700859700762	9.447115384615385	-12.577019344618241	FGF23;KIT
KEGG_2021_Human	Phototransduction	1/28	0.034145086039632476	0.21245831313549093	33.09053497942387	-17.550803279788266	RHO
KEGG_2021_Human	Epithelial cell signaling in Helicobacter pylori infection	1/70	0.08339759626885078	0.2479924282362839	12.880837359098228	-7.74542097629872	PTPN11
KEGG_2021_Human	Insulin resistance	1/108	0.12599902727061665	0.2479924282362839	8.2668743509865	-4.943743954376122	PTPN11
KEGG_2021_Human	Central carbon metabolism in cancer	1/70	0.08339759626885078	0.2479924282362839	12.880837359098228	-7.74542097629872	KIT
KEGG_2021_Human	Fc epsilon RI signaling pathway	1/68	0.0811045146521906	0.2479924282362839	13.26865671641791	-7.96724592924887	MAP2K7
KEGG_2021_Human	Fluid shear stress and atherosclerosis	1/139	0.15942370386618251	0.2479924282362839	6.384863123993559	-3.698840756963446	MAP2K7
KEGG_2021_Human	Adipocytokine signaling pathway	1/69	0.08225170002715665	0.2479924282362839	13.071895424836601	-7.854937277937848	PTPN11
KEGG_2021_Human	Chronic myeloid leukemia	1/76	0.09024597396088518	0.2479924282362839	11.841481481481482	-7.141387005986298	PTPN11
KEGG_2021_Human	Growth hormone synthesis, secretion and action	1/119	0.13799386385009413	0.2479924282362839	7.4858757062146895	-4.435243302362896	GH1
KEGG_2021_Human	Hematopoietic cell lineage	1/99	0.11607356788707196	0.2479924282362839	9.036281179138323	-5.434068642481248	KIT
KEGG_2021_Human	Yersinia infection	1/137	0.15730251033809037	0.2479924282362839	6.480392156862745	-3.763669230249352	MAP2K7
KEGG_2021_Human	GnRH signaling pathway	1/93	0.1094003568916107	0.2479924282362839	9.632850241545894	-5.8073541800756905	MAP2K7
KEGG_2021_Human	C-type lectin receptor signaling pathway	1/104	0.12160016340314761	0.2479924282362839	8.592233009708737	-5.152341092635986	PTPN11
KEGG_2021_Human	Parathyroid hormone synthesis, secretion and action	1/106	0.12380207979004104	0.2479924282362839	8.426455026455027	-5.046288872333345	FGF23
KEGG_2021_Human	ErbB signaling pathway	1/85	0.10043221696214563	0.2479924282362839	10.56084656084656	-6.37671991533167	MAP2K7
KEGG_2021_Human	TNF signaling pathway	1/112	0.13037805537365837	0.2479924282362839	7.964964964964965	-4.748494648054986	MAP2K7
KEGG_2021_Human	T cell receptor signaling pathway	1/104	0.12160016340314761	0.2479924282362839	8.592233009708737	-5.152341092635986	MAP2K7
KEGG_2021_Human	Renal cell carcinoma	1/69	0.08225170002715665	0.2479924282362839	13.071895424836601	-7.854937277937848	PTPN11
KEGG_2021_Human	Relaxin signaling pathway	1/129	0.1487694756391342	0.2479924282362839	6.892361111111111	-4.041189892105298	MAP2K7
KEGG_2021_Human	PD-L1 expression and PD-1 checkpoint pathway in cancer	1/89	0.10492639565254669	0.2479924282362839	10.075757575757576	-6.080768259179883	PTPN11
KEGG_2021_Human	Pathways in cancer	2/531	0.13679480156092927	0.2479924282362839	3.5628544423440456	-3.410136075895621	FGF23;KIT
KEGG_2021_Human	Leukocyte transendothelial migration	1/114	0.13256015588280526	0.2479924282362839	7.822025565388397	-4.655477238055189	PTPN11
KEGG_2021_Human	Acute myeloid leukemia	1/67	0.07995603885498047	0.2479924282362839	13.47138047138047	-8.082458738692866	KIT
KEGG_2021_Human	Osteoclast differentiation	1/127	0.1466241030974613	0.2479924282362839	7.00352733686067	-4.115510268264927	MAP2K7
KEGG_2021_Human	Natural killer cell mediated cytotoxicity	1/131	0.1509099928727911	0.2479924282362839	6.7846153846153845	-3.968927686510734	PTPN11
KEGG_2021_Human	Melanoma	1/72	0.0856855265026792	0.2479924282362839	12.514866979655713	-7.534346814915346	FGF23
KEGG_2021_Human	Melanogenesis	1/101	0.11828795027183354	0.2479924282362839	8.853333333333333	-5.318405524022337	KIT
KEGG_2021_Human	Toll-like receptor signaling pathway	1/104	0.12160016340314761	0.2479924282362839	8.592233009708737	-5.152341092635986	MAP2K7
KEGG_2021_Human	Gastric cancer	1/149	0.16995776547310146	0.2572333747700995	5.945945945945946	-3.3986573195730956	FGF23
KEGG_2021_Human	Hepatitis B	1/162	0.18347437883820783	0.2698019005380287	5.456866804692892	-3.0596637281364782	MAP2K7
KEGG_2021_Human	Tight junction	1/169	0.19067020323006928	0.2698019005380287	5.224867724867725	-2.8972129419331236	MAP2K7
KEGG_2021_Human	Protein processing in endoplasmic reticulum	1/171	0.19271564324144907	0.2698019005380287	5.162091503267974	-2.8530763101358976	MAP2K7
KEGG_2021_Human	Axon guidance	1/182	0.2038826300760579	0.27847383620144495	4.841620626151013	-2.6265948500338347	PTPN11
KEGG_2021_Human	Kaposi sarcoma-associated herpesvirus infection	1/193	0.21491040066934372	0.27937458133338555	4.55787037037037	-2.4244944960200487	MAP2K7
KEGG_2021_Human	Regulation of actin cytoskeleton	1/218	0.2394639268571876	0.27937458133338555	4.019969278033794	-2.037730229066884	FGF23
KEGG_2021_Human	Proteoglycans in cancer	1/205	0.22678373523038298	0.27937458133338555	4.283224400871459	-2.2275706216550177	PTPN11
KEGG_2021_Human	Lipid and atherosclerosis	1/215	0.23655445762047492	0.27937458133338555	4.077881619937695	-2.079575623138921	MAP2K7
KEGG_2021_Human	Pathogenic Escherichia coli infection	1/197	0.21888628489075546	0.27937458133338555	4.462585034013605	-2.3563138595912863	PTPN11
KEGG_2021_Human	Epstein-Barr virus infection	1/202	0.22383065271253133	0.27937458133338555	4.3488114980652295	-2.274707784911856	MAP2K7
KEGG_2021_Human	Human immunodeficiency virus 1 infection	1/212	0.23363497492364255	0.27937458133338555	4.137440758293839	-2.12256354972075	MAP2K7
KEGG_2021_Human	Calcium signaling pathway	1/240	0.2604969587424048	0.29771080999131977	3.6397024639702464	-1.7619943041292825	FGF23
KEGG_2021_Human	Salmonella infection	1/249	0.2689494049142217	0.30122333350392827	3.503584229390681	-1.6629804039719844	MAP2K7
KEGG_2021_Human	Cytokine-cytokine receptor interaction	1/295	0.310808292768788	0.34127969402062996	2.9380196523053668	-1.2513063817932166	GH1
KEGG_2021_Human	Huntington disease	1/306	0.32049274018188956	0.34514602788818877	2.8280510018214935	-1.1715156192121785	MAP2K7
KEGG_2021_Human	Neuroactive ligand-receptor interaction	1/341	0.3504975915199974	0.37033707783245007	2.5254901960784313	-0.9533164047874388	GH1
KEGG_2021_Human	Alzheimer disease	1/369	0.3736370340305108	0.38747544269830747	2.32487922705314	-0.8103995559567543	MAP2K7
KEGG_2021_Human	Pathways of neurodegeneration	1/475	0.45466905008847364	0.46293576009008225	1.7801218940459447	-0.4367315309409891	MAP2K7
KEGG_2021_Human	Herpes simplex virus 1 infection	1/498	0.4709527127104428	0.4709527127104428	1.6926000447127207	-0.379898711570649	PTPN11
